Clinical Trial Update: Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing direct thrombin inhibitors to low molecular weight heparin in patients with Staphylococcus aureus bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Direct thrombin inhibitors
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Staphylococcus Aureus Bacteraemia | Phase 2 | Status: COMPLETED